首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18177篇
  免费   1256篇
  国内免费   474篇
耳鼻咽喉   83篇
儿科学   125篇
妇产科学   12篇
基础医学   1611篇
口腔科学   2076篇
临床医学   2079篇
内科学   730篇
皮肤病学   31篇
神经病学   278篇
特种医学   1629篇
外科学   6707篇
综合类   2374篇
预防医学   658篇
眼科学   17篇
药学   631篇
  21篇
中国医学   664篇
肿瘤学   181篇
  2024年   21篇
  2023年   386篇
  2022年   592篇
  2021年   878篇
  2020年   986篇
  2019年   718篇
  2018年   710篇
  2017年   787篇
  2016年   626篇
  2015年   603篇
  2014年   1353篇
  2013年   1417篇
  2012年   1041篇
  2011年   1096篇
  2010年   957篇
  2009年   884篇
  2008年   841篇
  2007年   820篇
  2006年   794篇
  2005年   618篇
  2004年   629篇
  2003年   465篇
  2002年   386篇
  2001年   345篇
  2000年   261篇
  1999年   257篇
  1998年   193篇
  1997年   186篇
  1996年   116篇
  1995年   127篇
  1994年   97篇
  1993年   97篇
  1992年   83篇
  1991年   52篇
  1990年   40篇
  1989年   49篇
  1988年   46篇
  1987年   46篇
  1986年   35篇
  1985年   29篇
  1984年   37篇
  1983年   37篇
  1982年   36篇
  1981年   27篇
  1980年   17篇
  1979年   19篇
  1978年   18篇
  1977年   13篇
  1976年   15篇
  1975年   9篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的通过测量锁骨钩钢板内固定术后患者影像学资料,分析发生肩峰骨侵蚀的原因是否与钢板钩-肩峰匹配度相关。 方法回顾性分析2015年8月1日至2018年8月31日期间在上海市浦东医院骨科就诊的210例患者的影像学资料,210例患者均因肩锁关节脱位或锁骨远端骨折行锁骨钩钢板内固定治疗,其中男110例、女100例;年龄24~76岁,平均(44.60±8.75)岁;肩锁关节脱位70例,锁骨远端骨折140例。测量术后及终末随访患者肩锁关节正位X线片相关数据,按锁骨钩钢板术后是否发生肩峰骨侵蚀,将纳入患者分为3组:无骨侵蚀组(A组)、伴钢板钩移位骨侵蚀组(B组)、不伴移位的骨侵蚀组(C组),分别测量钢板钩-肩峰的匹配度(β),统计分析术后发生肩峰骨侵蚀与钢板钩-肩峰匹配度之间的关系。 结果纳入研究的210例患者术后随访24~64周,平均(32.0±6.5)周。A组患者115例,B组患者54例,C组患者41例。A组匹配度β(3.72±0.48)mm与B组β1(6.91±0.84)mm比较差异有统计学意义(P<0.05);A组匹配度β(3.72±0.48)mm与C组β2(5.88±0.65)mm比较差异有统计学意义(P<0.05);B组匹配度β1(6.91±0.84)mm与C组β2(5.88±0.65)mm比较差异有统计学意义(P<0.05)。 结论锁骨钩钢板内固定术后是否发生肩峰骨侵蚀与钢板钩-肩峰匹配度β存在明显相关性,钢板钩与肩峰之间的匹配度越好,β值越小,发生肩峰骨侵蚀的可能性更小。  相似文献   
2.
目的探讨针刺联合中药熏蒸对踝关节骨折术后患者踝关节功能及骨代谢指标的影响。方法以沈阳市第一人民医院收治的110例接受手术治疗的踝关节骨折患者作为研究对象,随机分为对照组和试验组,各55例。对照组给予常规康复训练,试验组在此基础上应用针刺联合中药熏蒸治疗,治疗3个月。比较两组总体疗效,观察两组踝关节量表(Olerud-Molander、Baird)评分变化情况、踝关节功能包括踝关节肌力和关节主动活动度以及骨代谢指标改善情况。结果试验组优良率高于对照组(70.91%vs.43.63%,P<0.05)。治疗后,两组患者Baird踝关节评分、Olerud-Molander功能评分均明显升高(P<0.05);踝关节肌力和关节主动活动度均提升(P<0.05);骨代谢指标血清骨钙素(BGP)、前胶原氨基端肽(PINP)、前胶原羧基端肽(PICP)、血清总骨Ⅰ型前胶原氨基端延长肽(Total-PINP)和Ⅰ型胶原羧基端肽β特殊序列(β-CTX)水平降低(P<0.05);试验组各指标改善均优于对照组(P<0.05)。结论针刺联合中药熏蒸具有活血止痛、化瘀消肿、补肾壮骨之效,作用于踝关节骨折术后患者,可有效恢复其踝关节功能,缓解关节疼痛、肿胀症状,调节骨代谢指标,对于踝关节骨折术后有较好的治疗效果。  相似文献   
3.
目的探讨一种自拟中药配方制成的护膝治疗膝关节骨性关节炎(knee osteoarthritis,KOA)的临床疗效。方法本次研究选择2020年6月至12月于联勤保障部队临潼康复疗养中心进行治疗的160例确诊为KOA的患者作为研究对象,根据临床治疗方法将全部患者随机分成两组,每组80例,比较两组临床效果。结果比较后发现,总有效率观察组为61.25%;对照组为37.50%,差异有统计学意义;膝关节Lysholm评分对比显示,两组患者的膝关节功能都有明显改善,且观察组治疗效果明显优于对照组,差异有统计学意义。结论该自制护膝对于KOA患者有很好的治疗效果,能显著改善患者关节的各项功能。  相似文献   
4.
Mycoplasma hominis is a commensal pathogen normally found in urogenital tract of humans and has been associated with a wide variety of extra-genitourinary infections, such as mediastinitis, bacteremia, and septic arthritis, particularly in immunocompromised patients. Here, we present a case of a 48-year-old male, who had been treated with fingolimod for relapsing multiple sclerosis and presented with fever and right-sided hip pain following total hip arthroplasty. CT scan revealed localized fluid collection in the right quadriceps femoris muscle adjacent to the joint cavity of right hip. The percutaneously aspirated fluid grew M. hominis, which was also isolated from blood culture. With diagnosis of periprosthetic joint infection, the patient underwent surgical debridement with retained prosthesis and was treated with antimicrobial agents. Infected granulation tissues excised from the hip was observed under an electron microscope, which revealed electron-dense rounded structures contained in neutrophils, consistent with Mycoplasma particles. Fingolimod, an immunomodulatory drug that acts on the sphingosine-1-phosphate receptor and prevents the egress of lymphocytes from lymph nodes, might increase host susceptibility to a systemic M. hominis infection.  相似文献   
5.
6.
This study aims to describe intraoperative complications in temporomandibular joint arthroscopy in patients with Wilkes stage II, III y IV. An analytic observational retrospective study. Inclusion criteria were patients who had no improvement with conservative treatment diagnosed as Wilkes II stage to Wilkes stage IV, and no previous TMJ surgery. Exclusion criteria were disc perforation observed by arthroscopy. Data collected from 458 patients (899 arthroscopies). Of this population, 772 (85.8%) arthroscopies correspond to women, and 127 men (14.1%). Of the sample evaluated, 368 (40.9%) were arthroscopic without discopexy, and 531 (59%) were arthroscopic with discopexy using resorbable pins. In total, 330 complications (36.7%) were found, of which 293 (32.5%) were implicated with iatrogenic damage to the anatomy, and 36 (4%) were associated with some instrument failure. Of this total number of complications, 191 (51.9%) of 386 corresponded to the arthroscopy without discopexy group and 138 (25.9%) of 531 corresponded to the arthroscopy with discopexy group. These study data suggest that the main complications were irrigation fluid extravasation (p = 0.000), and intra-articular bleeding (p = 0.001) followed by pin problems (p = 0.001) in cases of arthroscopies with discopexy. Within the limitations of the study it seems that the learning curve has an important influence on the occurrence of complications. At the beginning of the learning curve, complications are more related to anatomy. Afterwards, the rate of complications decreases but they are more related to the instruments used in advanced techniques. Therefore, proper training and a wide learning curve can reduce the risk of complications and if any occur, more timely management could be given.  相似文献   
7.
This study evaluates the impact of tooth-borne Surgically Assisted Rapid Mandibular Expansion (SARME) on the temporomandibular joint (TMJ) function and condylar morphology.Medical records of patients who received a SARME between 2014 and 2018 are retrospectively reviewed concerning functional problems. Morphological changes of the condyles are analyzed by means of surface registration of 3D reconstructed CBCT scans preoperatively and one-year postoperatively, and correlated to functional outcome.In 68 patients data are complete. The risk of TMJ dysfunction is slightly increased from 18 to 25% at a mean of 14 months after SARME. This is attributed to an increase in the number of minor problems (75–82%). The presence of complaints before SARME is the only identifiable risk factor for also having complaints after the intervention (p = 0.0019). In one patient with pre-existent TMJ dysfunction complaints deteriorated after SARME. After SARME no cases of extended condylar resorption are described. There is no correlation between morphological condylar changes and the prevalence of TMJ dysfunction (p = 0.7121 for appositional and p = 0.3038 for resorptive changes). However, appositional and resorptive changes at the condylar head appear to correlate with growth potential, based on age, gender and skeletal deformity (p < 0.0001 and p = 0.0154 respectively).Within the limitations of the study it seems that SARME does not have a negative impact on TMJ function or condylar integrity and, therefore, the choice for or against this approach can be made without considering consequences for TMJ a major issue for the decision.  相似文献   
8.
目的:观察mini-Swashbuckler入路联合股骨外侧微创内固定系统(LISS)治疗股骨远端骨折患者的效果。方法:选取80例股骨远端骨折患者为研究对象,按照随机数字表法分为对照组与观察组各40例。对照组采用传统Swashbuckler入路联合LISS治疗,观察组采用mini-Swashbuckler入路联合LISS治疗,比较两组临床相关指标水平、膝关节功能[美国特种外科医院膝关节功能(HSS)]评分、并发症发生率和生命质量[简明健康状况调查量表(SF-36)]评分。结果:观察组手术时间长于对照组,术中出血量少于对照组,差异有统计学意义(P<0.05);两组住院时间和骨折愈合时间比较,差异无统计学意义(P>0.05);术后3、6个月时,观察组HSS评分均高于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为5.00%(2/40),与对照组的10.00%(4/40)比较,差异无统计学意义(P>0.05);术后6个月,两组SF-36评分均高于术前,且观察组高于对照组,差异有统计学意义(P<0.05)。结论:mini-Swashbuckler入路联合LISS治疗股骨远端骨折患者可减少术中出血量,提高HSS和SF-36评分,效果优于传统Swashbuckler入路联合LISS治疗,但手术时间长于传统Swashbuckler入路联合LISS治疗。  相似文献   
9.
目的 观察超声引导下关节腔内注射重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白(益赛普)治疗血友病性关节病(HA)的价值。方法 回顾性分析32例接受超声引导下穿刺关节腔注射益赛普的HA患者,对比观察治疗前及治疗后1个月血友病关节健康评分(HJHS)、视觉模拟评分(VAS),以及超声所示目标关节增生滑膜厚度、血流信号、Melchiorre及中国早期血友病性关节病超声检测(HEAD-US-C)评分,评估其治疗价值。结果 对32例均成功完成超声引导下穿刺关节腔及腔内注射益赛普,共对18例膝关节、7例肘关节及7例踝关节进行治疗。术后未出现感染、出血等并发症。治疗后1个月,目标关节HJHS、VAS、Melchiorre评分、HEAD-US-C评分及增生滑膜最大厚度、平均厚度、血流信号均低于治疗前(P均<0.01)。结论 超声引导下关节腔内注射益赛普治疗HA安全、有效。  相似文献   
10.
BackgroundWhile studies have demonstrated favorable outcomes in utilization of primary total shoulder arthroplasty (TSA) for the treatment of glenohumeral osteoarthritis (OA), adverse events such as infections can still occur. Periprosthetic joint infections (PJIs) are associated with worse outcomes and patient morbidity. The purpose of this study was to: (1) compare patient demographics amongst TSA patients with and without PJIs following primary TSA; and (2) identify patient-related risk factors for PJIs following primary TSA.MethodsPatients undergoing primary TSA for the treatment of glenohumeral OA were identified using the Mariner administrative claims database by CPT code 23,472. Laterality modifiers were utilized to ensure PJIs were developing in the correct laterality as those patients undergoing primary TSA. Inclusion for the study group consisted of patients who developed PJIs within 2-years after the index procedure, whereas patients who did not develop PJIs served as the comparison cohort. Primary outcomes analyzed included patient demographics and patient-related risk factors for PJIs following primary TSA. A stepwise backwards elimination multivariate binomial logistic regression analyses was performed to determine the odds (OR) of PJIs in patients undergoing primary TSA. A P value less than .05 was considered statistically significant.ResultsThe query yielded 15,396 patients who underwent primary TSA for glenohumeral OA, of which 191 patients developed PJIs and 15,205 did not develop PJIs. The study found statistically significant differences amongst patients who did and did not develop PJIs following primary TSA with respect to age, sex, and presence of comorbid conditions. Risk factors associated with developing PJIs following primary TSA included: pathologic weight loss (OR: 2.06, P < .0001), obesity (OR: 1.56, P = .0001), male sex (OR: 1.52, P = .007), and peripheral vascular disease (OR: 1.46, P = .022).ConclusionAs the number of primary TSAs for the treatment of glenohumeral OA increase worldwide, identifying modifiable risk-factors to reduce the incidence of infection is critical. The study found various modifiable and non-modifiable risk factors associated with developing PJIs following primary TSA. This study is valuable to orthopedists in order to identify and risk-stratify patients with regard to PJI in the setting of primary TSA for OA.Level of EvidenceLevel III; Case-Control Study  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号